Clinical Trial Update: Short Course Neoadjuvant Chemo-radiotherapy Plus Toripalimab for Locally Advanced Resectble Squamous Cell Carcinoma of Esophagus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating short-course neoadjuvant chemo-radiotherapy plus toripalimab for locoregionally advanced resectable esophageal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Chemotherapy and radiotherapy regimen (unspecified)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Jiangsu Cancer Institute & Hospital | Conditions: Locally Advanced Esophageal Carcinoma | Phase 2 | Status: UNKNOWN